KalVista Pharmaceuticals, Inc. - Common Stock (KALV)
12.45
+0.02 (0.16%)
Kalvista Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative therapies for diseases involving proteins called "kinases," which play a crucial role in various cellular processes
The company specializes in creating small molecule drugs aimed at treating chronic and rare diseases, particularly in areas such as ophthalmology and hereditary angioedema. With a commitment to employing advanced drug design and development techniques, Kalvista aims to address unmet medical needs and improve patient outcomes through its targeted therapeutic approaches.
Frequently Asked Questions
Is KalVista Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, KalVista Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does KalVista Pharmaceuticals, Inc. - Common Stock trade on?
KalVista Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for KalVista Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for KalVista Pharmaceuticals, Inc. - Common Stock is KALV on the Nasdaq Stock Market
What is the current price of KalVista Pharmaceuticals, Inc. - Common Stock?
The current price of KalVista Pharmaceuticals, Inc. - Common Stock is 12.45
When was KalVista Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of KalVista Pharmaceuticals, Inc. - Common Stock was at 4:00 pm EDT on March 12th, 2025
What is the market capitalization of KalVista Pharmaceuticals, Inc. - Common Stock?
The market capitalization of KalVista Pharmaceuticals, Inc. - Common Stock is 426.21M
How many shares of KalVista Pharmaceuticals, Inc. - Common Stock are outstanding?
KalVista Pharmaceuticals, Inc. - Common Stock has 34.23M shares outstanding.